Startseite Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices

  • Sascha Dierks EMAIL logo , Reiner Andag , Friederike Gauss , Kathrin Budde , Paul Francke , Manuela Peschka , Andreas Fischer , Julie Schanz und Astrid Petersmann
Veröffentlicht/Copyright: 25. April 2022
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Objectives

Thyroid-stimulating hormone (TSH) is the routine primary screening test to assess thyroid function and rapid measurement of TSH levels is highly desirable especially in emergency situations. In the present study, we compared the analytical performance of a commercially available point-of-care test (AFIAS-1) and five laboratory-based systems.

Methods

Left over material of 60 patient plasma samples was collected from patient care and used in the respective assay. For statistical analysis of the produced data Bland-Altman and Passing-Bablok regression analysis were applied.

Results

Good correlation (r=0.982 or higher) was found between all devices. Slopes from regression analysis ranged from 0.972 (95% CI: 0.927–1.013) to 1.276 (95% CI: 1.210–1.315). Among the compared devices, imprecision was high in terms of coefficient of variation (CV=10.3%) for low TSH concentrations and lower (CV=7.3%) for high TSH concentrations. Independent of the method used, we demonstrated a poor standardization of TSH assays, which might impact clinical diagnosis e.g. of hyperthyreosis.

Conclusions

This study shows that the point-of-care (POC) test AFIAS-1 can serve as an alternative to laboratory-based assays. In addition the data imply that better standardization of TSH measurements is needed.


Corresponding author: Sascha Dierks, Institute of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany, Phone: +49 551 39 65698, E-mail:

  1. Research funding: This study was partly funded by nal von minden GmbH (Goettingen, Germany).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ Institutional Review Board (No.: 24/11/21).

  6. Data availability: The dataset is available in the Supplementary Material.

References

1. Rose, SR, Brown, RS, Foley, T, Kaplowitz, PB, Kaye, CI, Sundararajan, S, et al.. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290–303. https://doi.org/10.1542/peds.2006-0915.Suche in Google Scholar PubMed

2. Santos de los, ET, Starich, GH, Mazzaferri, EL. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 1989;149:526–32.10.1001/archinte.1989.00390030032006Suche in Google Scholar

3. Ross, DS, Burch, HB, Cooper, DS, Greenlee, MC, Laurberg, P, Maia, AL, et al.. American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016;26:1343–421. https://doi.org/10.1089/thy.2016.0229.Suche in Google Scholar PubMed

4. Rhee, CM, Bhan, I, Alexander, EK, Brunelli, SM. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 2012;172:153–9. https://doi.org/10.1001/archinternmed.2011.677.Suche in Google Scholar PubMed

5. Lee, SY, Rhee, CM, Leung, AM, Braverman, LE, Brent, GA, Pearce, EN. A review: radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab 2015;100:376–83. https://doi.org/10.1210/jc.2014-3292.Suche in Google Scholar PubMed PubMed Central

6. Dunne, P, Kaimal, N, MacDonald, J, Syed, AA. Iodinated contrast-induced thyrotoxicosis. CMAJ (Can Med Assoc J) 2013;185:144–7. https://doi.org/10.1503/cmaj.120734.Suche in Google Scholar PubMed PubMed Central

7. Andreucci, M, Solomon, R, Tasanarong, A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. BioMed Res Int 2014;2014:741018. https://doi.org/10.1155/2014/741018.Suche in Google Scholar PubMed PubMed Central

8. Völzke, H, Lüdemann, J, Robinson, DM, Spieker, KW, Schwahn, C, Kramer, A, et al.. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003;13:803–10.10.1089/105072503768499680Suche in Google Scholar PubMed

9. Soh, SB, Aw, TC. Laboratory testing in thyroid conditions – pitfalls and clinical utility. Ann Lab Med 2019;39:3–14. https://doi.org/10.3343/alm.2019.39.1.3.Suche in Google Scholar PubMed PubMed Central

10. Spencer, CA, Hollowell, JG, Kazarosyan, M, Braverman, LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007;92:4236–40. https://doi.org/10.1210/jc.2007-0287.Suche in Google Scholar PubMed

11. Brabant, G, Beck-Peccoz, P, Jarzab, B, Laurberg, P, Orgiazzi, J, Szabolcs, I, et al.. Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol 2006;154:633–7. https://doi.org/10.1530/eje.1.02136.Suche in Google Scholar

12. Biondi, B. The normal TSH reference range: what has changed in the last decade? J Clin Endocrinol Metab 2013;98:3584–7. https://doi.org/10.1210/jc.2013-2760.Suche in Google Scholar

13. Langén, VL, Niiranen, TJ, Mäki, J, Sundvall, J, Jula, AM. Thyroid-stimulating hormone reference range and factors affecting it in a nationwide random sample. Clin Chem Lab Med 2014;52:1807–13.10.1515/cclm-2014-0287Suche in Google Scholar

14. Gross, J, Dirzus, I. Die Laborzentralisierung und die Entwicklung der Pathologischen und Klinischen Biochemie an der Charité. Z Med Labdiagn 1989;30:83–9.Suche in Google Scholar

15. Plebani, M. Clinical laboratories: production industry or medical services? Clin Chem Lab Med 2015;53:995–1004. https://doi.org/10.1515/cclm-2014-1007.Suche in Google Scholar

16. Wickham, H. ggplot2. Cham: Springer International Publishing; 2016.10.1007/978-3-319-24277-4Suche in Google Scholar

17. RStudio Team. RStudio: Integrated Development Environment for R Studio. Boston, Ma: PBC; 2020.Suche in Google Scholar

18. Conn, JJ, Sebastian, MJ, Deam, D, Tam, M, Martin, FI. A prospective study of the effect of nonionic contrast media on thyroid function. Thyroid 1996;6:107–10. https://doi.org/10.1089/thy.1996.6.107.Suche in Google Scholar

19. Martin, FI, Tress, BW, Colman, PG, Deam, DR. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med 1993;95:78–82. https://doi.org/10.1016/0002-9343(93)90235-h.Suche in Google Scholar

20. Zhang, S, Cheng, F, Wang, H, Wen, J, Zeng, J, Zhang, C, et al.. Comparability of thyroid-stimulating hormone immunoassays using fresh frozen human sera and external quality assessment data. PLoS One 2021;16:e0253324. https://doi.org/10.1371/journal.pone.0253324.Suche in Google Scholar PubMed PubMed Central

21. Di Cerbo, A, Quagliano, N, Napolitano, A, Pezzuto, F, Iannitti, T, Di Cerbo, A. Comparison between an emerging point-of-care tool for TSH evaluation and a centralized laboratory-based method in a cohort of patients from Southern Italy. Diagnostics 2021;11:1590. https://doi.org/10.3390/diagnostics11091590. 34573932.Suche in Google Scholar PubMed PubMed Central

22. Reference Institute for Bioanalytics. Surveys Hormones Group 1 2021: TSH [Internet]. RfB; 2021. Available from: https://rfb.bio/cgi/results?rv_type=HM&rvTypeForDetails=HM&year=2021&rv_num=2&analyte=all&searchType=rv_type.Suche in Google Scholar

23. Walger, M. Publication of the English version of the Rili-BAEK guideline – the diagnostics industry’s view on the Rili-BAEK guideline and its ramifications on laboratory medicine in Germany. LaboratoriumsMedizin 2015;39:21. https://doi.org/10.1515/labmed-2015-0012.Suche in Google Scholar

24. Bolodeoku, J, Bains, S, Pinkney, S, Coker, O, Kim, TK, Anyaeche, C. An evaluation of the Boditech i-CHROMATM thyroid-stimulating hormone(TSH) method: precision and accuracy. Ann Clin Lab Res 2019;7:302.Suche in Google Scholar

25. Männistö, T, Surcel, H-M, Bloigu, A, Ruokonen, A, Hartikainen, A-L, Järvelin, M-R, et al.. The effect of freezing, thawing, and short- and long-term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks. Clin Chem 2007;53:1986–7. https://doi.org/10.1373/clinchem.2007.091371.Suche in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2022-0054).


Received: 2022-01-20
Accepted: 2022-03-31
Published Online: 2022-04-25
Published in Print: 2022-06-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. The never-ending quest for antibody assays standardization and appropriate measurement units
  4. Review
  5. Glycated albumin in diabetes mellitus: a meta-analysis of diagnostic test accuracy
  6. Opinion Paper
  7. Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group
  8. Guidelines and Recommendations
  9. Recommendations for IVDR compliant in-house software development in clinical practice: a how-to paper with three use cases
  10. General Clinical Chemistry and Laboratory Medicine
  11. Comparison between polynomial regression and weighted least squares regression analysis for verification of analytical measurement range
  12. Transport stability profiling – a proposed generic protocol
  13. Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes
  14. Development of a liquid chromatography mass spectrometry method for the determination of vitamin K1, menaquinone-4, menaquinone-7 and vitamin K1-2,3 epoxide in serum of individuals without vitamin K supplements
  15. TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism
  16. Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices
  17. Lack of analytical interference of dydrogesterone in progesterone immunoassays
  18. A comprehensive comparison between ISAC and ALEX2 multiplex test systems
  19. Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
  20. Importance of cerebrospinal fluid storage conditions for the Alzheimer’s disease diagnostics on an automated platform
  21. Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations
  22. An automated, rapid fluorescent immunoassay to quantify serum soluble programmed death-1 (PD-1) protein using testing-on-a-probe biosensors
  23. Hematology and Coagulation
  24. The VES-Matic 5 system: performance of a novel instrument for measuring erythrocyte sedimentation rate
  25. Cancer Diagnostics
  26. Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis
  27. Cardiovascular Diseases
  28. The intra-individual variation of cardiac troponin I: the effects of sex, age, climatic season, and time between samples
  29. Infectious Diseases
  30. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers
  31. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens
  32. Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
  33. Letters to the Editors
  34. Misleading nomenclature of units of WHO materials used for standardization of SARS COv-2 serology
  35. Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster
  36. COVID-19 related mortality and religious denomination vs. genetics
  37. Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer
  38. Effects of different pepsinogen cut offs in the screening of apparently healthy people
  39. Low levels of G17 and Barrett esophagus: a clinical relationship
  40. (In)direct chloride ISE measurements, room for improvement
  41. New concept of interactive academic poster used in medical scientific congress presented in the EuroMedLab 2021 Munich Session
Heruntergeladen am 30.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0054/html?lang=de
Button zum nach oben scrollen